Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions
When available estimates are limited, using novel search strategies to identify utilities of clinically similar conditions could be an approach for overcoming the information gap. However, it requires careful evaluation of the utility instruments, tariffs, and raters (proxy or self).
Authors
- Alexa C. Klimchak (ORCID: https://orcid.org/0000-0001-8196-7093)
- Rachel Salazar (ORCID: https://orcid.org/0000-0002-0644-5954)
- Lauren E. Sedita (ORCID: https://orcid.org/0000-0003-0899-1585)
- A. Lauren (ORCID: https://orcid.org/0000-0003-0088-1111)
- David D. Kim (ORCID: https://orcid.org/0000-0002-3383-8972)
Institutions
- Tufts Medical Center (US)
- University of Chicago (US)
- Sarepta Therapeutics (United States) (US)
Publication Details
- Journal
- Health and Quality of Life Outcomes
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1186/s12955-024-02287-2
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sarepta Therapeutics